Dr. Turcotte is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2450 Riverside Ave
Minneapolis, MN 55454Phone+1 612-365-8100Fax+1 612-365-8101- Is this information wrong?
Summary
- Dr. Lucie Turcotte is a pediatric hematologist/oncologist in Minneapolis, MN and is affiliated with multiple hospitals in the area, including University of Minnesota Masonic Children's Hospital, Hennepin Healthcare, and Essentia Health. She received her medical degree from University of Minnesota Medical School and has been in practice 11 years. She is experienced in leukemia, lymphoma and cancer survivorship care.
Education & Training
- University of MinnesotaMS, Clinical Research, 2015
- University of MinnesotaFellowship, Pediatric Hematology/Oncology, 2010 - 2013
- University of WashingtonResidency, Pediatrics, 2007 - 2010
- University of Minnesota Medical SchoolClass of 2007
- University of MinnesotaMPH, Maternal and Child Health, 2005
- University of Notre DameBS, Biological Sciences, 2002
Certifications & Licensure
- MN State Medical License 2010 - 2024
- WA State Medical License 2007 - 2010
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Clinical Excellence Honoree University of Minnesota Physicians, 2021-2023
- Top Doctor Minnesota Monthly Magazine, 2016-2023
- Order of the Eastern Star Scholar
- Join now to see all
Publications & Presentations
PubMed
- Impact of Risk-Based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the childhood cancer survivor study.Cohn, S. L., Danielle Novetsky Friedman, Pamela J Goodman, Wendy M Leisenring, Lisa R Diller, Susan L Cohn, Rebecca M Howell, Susan A Smith, Emily S Tonorezos, Suzanne...> ;Journal of the National Cancer Institute. 2024 Mar 9
- Polygenic risk scores, radiation treatment exposures and subsequent cancer risk in childhood cancer survivors.Todd M Gibson, Danielle M Karyadi, Stephen W Hartley, Michael A Arnold, Amy Berrington de Gonzalez, Miriam R Conces, Rebecca M Howell, Vidushi Kapoor, Wendy M Leisenri...> ;Nature Medicine. 2024 Mar 7
- 1 citationsTemporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor Study.Peter M K de Blank, Katharine R Lange, Mengqi Xing, Sedigheh Mirzaei Salehabadi, Deokumar Srivastava, Tara M Brinkman, Kirsten K Ness, Kevin C Oeffinger, Joseph Neglia...> ;Nature Cancer. 2024 Mar 1
- Join now to see all
Journal Articles
- Pro-inflammatory cytokine and adipokines levels in adult unrelated marrow donors are not associated with hematopoietic cell transplantation outcomesTurcotte LM, Wang T, Hemmer MT, Spellman SR, Arora M, Yingst A, Couriel D, Alousi A, Pidala J, Knight J, Verneris MR., Biology of Blood and Marrow Transplantation, 1/1/2018
- A pilot study evaluating chemotherapy tolerability for breast cancer patients who have received prior treatment and chest radiation for Hodgkin lymphomaWatson AP, Peterson B, Vogel R, Baxstrom K, Lee C, Turcotte L, Blaes A., Cancer Treatment and Research Communications, 1/1/2018
- Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantationTurcotte LM, Knight JM, Spellman S, Arora M, Wang T, Hemmer M, Verneris MR., Bone Marrow Transplantation, 1/1/2018
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Socioeconomic Status Is Associated with Prognostic Factors in Childhood Acute Lymphoblastic Leukemia - Implications for Outcomes: A Report from the Children's Oncology...Lucie M Turcotte, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Pre-Transplant Serum Claudin-3 Predicts Intestinal Graft-Versus-Host Disease and Non-Relapse Mortality Risk after Allogeneic Hematopoietic Cell TransplantationLucie M Turcotte, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Monocyte subpopulation recovery and outcomes following hematopoietic cell transplantationTurcotte LM, Cao Q, Krahn E, Curtsinger J, Yingst AM, Cooley S, Brunstein CG, MacMillan ML, Holtan SG, Wagner JE, Weisdorf DJ, Blazar BR, Miller JS, Verneris MR., American Society of Hematology Annual Meeting, San Diego, CA, 1/1/2016
- Join now to see all
Lectures
- Chronic Health Conditions and Late Mortality Among Survivors of Childhood Acute Myeloid Leukemia: A Report from the Childhood Cancer Survivor Study (CCSS)Clinically Re...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Subsequent malignant neoplasms (SMNs) among non-irradiated survivors of childhood cancer treated with chemotherapy in the Childhood Cancer Survivor Study.2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
- Subsequent Malignant Neoplasms Among Non-Irradiated Survivors of Childhood Cancer Treated with Chemotherapy in the Childhood Cancer Survivor Study.1/1/2018
- Join now to see all
Press Mentions
- Double TroubleDecember 1st, 2021
- Clinical Challenges: Pediatric ALL in Children with ObesityJune 14th, 2021
- Second Cancer in Survivors a Complex, Multifaceted ConcernMarch 13th, 2021
- Join now to see all
Hospital Affiliations
- M Health Fairview Masonic Children’s HospitalMinneapolis, Minnesota
- Hennepin HealthcareMinneapolis, Minnesota
- M Health Fairview University of Minnesota Medical CenterMinneapolis, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: